top of page
< Back

Towards routine HPA-screening in pregnancy to prevent FNAIT: Assessing disease burden, optimising risk group selection and Safety of IVIg Treatment.

Prof D. Oepkes/Prof C.E. van der Schoot/Dr C. de Haas

Towards routine HPA-screening in pregnancy to prevent FNAIT: Assessing disease burden, optimising risk group selection and Safety of IVIg Treatment.

2014

bottom of page